BioCryst Reports Second Quarter 2014 Financial Results

Go back to BioCryst Reports Second Quarter 2014 Financial Results
BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) Delayed: 8.66 +0.23 (2.73%)
Previous Close $8.43    52 Week High $10.98 
Open $8.54    52 Week Low $1.63 
Day High $8.72    P/E N/A 
Day Low $8.43    EPS $-0.68 
Volume 1,752,506